Table for the 4 triples with object "The FDA notes that this is a "weak" CYP3A inhibitor in vivo in it most recent guidance document. See Table 5, p22" sorted by label

Subject	Predicate
?:evidence_1029	?:content
?:evidence_1473	?:content
?:evidence_1516	?:content
?:evidence_1633	?:content